Literature DB >> 6275976

The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage.

K Ohnishi, S Iida, S Iwama, N Goto, F Nomura, M Takashi, A Mishima, K Kono, K Kimura, H Musha, K Kotota, K Okuda.   

Abstract

To study the effects of habitual alcohol intake on the latency period for the development of liver cirrhosis and hepatocellular carcinoma (HCC), 158 patients with cirrhosis and 79 with HCC were analyzed with respect to age at the time of diagnosis. They were classified into four groups based on hepatitis B surface antigen (HBsAg) in serum, and the history of intake of more than one small bottle of Japanese "sake" or an equivalent per day for more than 10 years. The average age of HBsAg positive male cirrhotics with a drinking habit (n = 10) was 38.8 years, 10.5 years younger than that of those without a drinking habit (n = 8) (P less than 0.05). The average age of HBsAg negative cirrhotics with a drinking habit (n = 97) was 47.9 years, eight years younger than that of those not drinking (n = 36) (P less than 0.001). There was no significant difference in the laboratory data between these groups. The average age of the HBsAg positive HCC patients with a drinking habit (n = 20) was 48.9 years, nine years younger than that of those without a drinking habit (n = 12) (P less than 0.05). The average age of HBsAg negative male HCC cases with habitual intake of more than 126 ml of ethanol per day was 51.0 years (n = 8), ten years younger than that of nondrinking male HCC cases (n = 11) (P less than 0.05). These data suggest that habitual alcohol intake may promote the development of liver cirrhosis and HCC, especially in HBsAg carriers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6275976     DOI: 10.1002/1097-0142(19820215)49:4<672::aid-cncr2820490415>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Hepatic lesions in alcoholic HBV carriers.

Authors:  T Takahashi; T Kamimura; H Asakura; F Ichida
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 2.  Screening for hepatocellular carcinoma. Review and perspective.

Authors:  J C Ellis
Journal:  West J Med       Date:  1988-08

Review 3.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

4.  Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area.

Authors:  Hee-Won Kwak; Joong-Won Park; Young Hwan Koh; Ju Hee Lee; Ami Yu; Byung-Ho Nam
Journal:  Liver Cancer       Date:  2015-12-15       Impact factor: 11.740

Review 5.  Hepatitis B virus infection. Current concepts of chronicity and immunity.

Authors:  G N Vyas; H E Blum
Journal:  West J Med       Date:  1984-05

6.  Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis.

Authors:  T Chiba; Y Matsuzaki; M Abei; J Shoda; T Aikawa; N Tanaka; T Osuga
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 7.  Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.

Authors:  R Naccarato; F Farinati
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

8.  Hepatitis B and C markers among alcoholics in Israel: high incidence of HCV infection.

Authors:  I Srugo; E Shinar; S Bar-Shany; L Amos
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

Review 9.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

10.  Prevalence of hepatitis B virus markers among Polish urban alcoholics.

Authors:  T Laskus; E Lupa; E Szczutowska; L Babiuch
Journal:  Infection       Date:  1988       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.